Classification model based on strain measurements to identify patients with arrhythmogenic cardiomyopathy with left ventricular involvement.


Journal

Computer methods and programs in biomedicine
ISSN: 1872-7565
Titre abrégé: Comput Methods Programs Biomed
Pays: Ireland
ID NLM: 8506513

Informations de publication

Date de publication:
May 2020
Historique:
received: 22 03 2019
revised: 22 11 2019
accepted: 21 12 2019
pubmed: 10 1 2020
medline: 9 2 2021
entrez: 10 1 2020
Statut: ppublish

Résumé

A heterogenous expression characterizes arrhythmogenic cardiomyopathy (AC). The evaluation of regional wall movement included in the current Task Force Criteria is only qualitative and restricted to the right ventricle. However, a strain-based approach could precisely quantify myocardial deformation in both ventricles. We aim to define and modelize the strain behavior of the left ventricle in AC patients with left ventricular (LV) involvement by applying algorithms such as Principal Component Analysis (PCA), clustering and naïve Bayes (NB) classifiers. Thirty-six AC patients with LV involvement and twenty-three non-affected family members (controls) were enrolled. Feature-tracking analysis was applied to cine cardiac magnetic resonance imaging to assess strain time series from a 3D approach, to which PCA was applied. A Two-Step clustering algorithm separated the patients' group into clusters according to their level of LV strain impairment. A statistical characterization between controls and the new AC subgroups was done. Finally, a NB classifier was built and new data from a small evolutive dataset was predicted. 60% of AC-LV patients showed mildly affected strain and 40% severely affected strain. Both groups and controls exhibited statistically significant differences, especially when comparing controls and severely affected AC-LV patients. The classification accuracy of the strain NB classifier reached 82.76%. The model performance was as good as to classify the individuals with a 100% sensitivity and specificity for severely impaired strain patients, 85.7% and 81.1% for mildly impaired strain patients, and 69.9% and 91.4% for normal strain, respectively. Even when the severely affected LV-AC group was excluded, LV strain showed a good accuracy to differentiate patients and controls. The prediction of the evolutive dataset revealed a progressive alteration of strain in time. Our LV strain classification model may help to identify AC patients with LV involvement, at least in a setting of a high pretest probability, such as family screening.

Sections du résumé

BACKGROUND AND OBJECTIVE OBJECTIVE
A heterogenous expression characterizes arrhythmogenic cardiomyopathy (AC). The evaluation of regional wall movement included in the current Task Force Criteria is only qualitative and restricted to the right ventricle. However, a strain-based approach could precisely quantify myocardial deformation in both ventricles. We aim to define and modelize the strain behavior of the left ventricle in AC patients with left ventricular (LV) involvement by applying algorithms such as Principal Component Analysis (PCA), clustering and naïve Bayes (NB) classifiers.
METHODS METHODS
Thirty-six AC patients with LV involvement and twenty-three non-affected family members (controls) were enrolled. Feature-tracking analysis was applied to cine cardiac magnetic resonance imaging to assess strain time series from a 3D approach, to which PCA was applied. A Two-Step clustering algorithm separated the patients' group into clusters according to their level of LV strain impairment. A statistical characterization between controls and the new AC subgroups was done. Finally, a NB classifier was built and new data from a small evolutive dataset was predicted.
RESULTS RESULTS
60% of AC-LV patients showed mildly affected strain and 40% severely affected strain. Both groups and controls exhibited statistically significant differences, especially when comparing controls and severely affected AC-LV patients. The classification accuracy of the strain NB classifier reached 82.76%. The model performance was as good as to classify the individuals with a 100% sensitivity and specificity for severely impaired strain patients, 85.7% and 81.1% for mildly impaired strain patients, and 69.9% and 91.4% for normal strain, respectively. Even when the severely affected LV-AC group was excluded, LV strain showed a good accuracy to differentiate patients and controls. The prediction of the evolutive dataset revealed a progressive alteration of strain in time.
CONCLUSIONS CONCLUSIONS
Our LV strain classification model may help to identify AC patients with LV involvement, at least in a setting of a high pretest probability, such as family screening.

Identifiants

pubmed: 31918194
pii: S0169-2607(19)30408-0
doi: 10.1016/j.cmpb.2019.105296
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105296

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yolanda Vives-Gilabert (Y)

Instituto ITACA, Universitat Politècnica de Valencia, Camino de Vera s/n,València 46022, Spain. Electronic address: yovigi@upv.es.

Esther Zorio (E)

Unidad de Cardiopatías Familiares, Muerte Súbita y Mecanismos de Enfermedad (CaFaMuSMe), Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell no. 106, Valencia, Spain; Unidad de Valoración del Riesgo de Muerte Súbita Familiar, Servicio de Cardiología, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain. Electronic address: zorio_est@gva.es.

Jorge Sanz-Sánchez (J)

Unidad de Cardiopatías Familiares, Muerte Súbita y Mecanismos de Enfermedad (CaFaMuSMe), Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell no. 106, Valencia, Spain; Unidad de Valoración del Riesgo de Muerte Súbita Familiar, Servicio de Cardiología, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Pilar Calvillo-Batllés (P)

Servicio de Radiología, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

José Millet (J)

Instituto ITACA, Universitat Politècnica de Valencia, Camino de Vera s/n,València 46022, Spain; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.

Francisco Castells (F)

Instituto ITACA, Universitat Politècnica de Valencia, Camino de Vera s/n,València 46022, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH